The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 19, 2011
Filed:
Feb. 29, 2008
Jack Nguyen, San Francisco, CA (US);
Gregory T. Went, Mill Valley, CA (US);
Paul Spence, Mill, CA (US);
Timothy J. Fultz, Pleasant Hill, CA (US);
David Chernoff, San Rafael, CA (US);
Terry L. Burkoth, Palo Alto, CA (US);
Rowan Chapman, Burlingame, CA (US);
Mickey S. Urdea, Alamo, CA (US);
Jack Nguyen, San Francisco, CA (US);
Gregory T. Went, Mill Valley, CA (US);
Paul Spence, Mill, CA (US);
Timothy J. Fultz, Pleasant Hill, CA (US);
David Chernoff, San Rafael, CA (US);
Terry L. Burkoth, Palo Alto, CA (US);
Rowan Chapman, Burlingame, CA (US);
Mickey S. Urdea, Alamo, CA (US);
Adamas Pharmaceuticals, Inc., Emeryville, CA (US);
Abstract
Kits comprising an M2 inhibitor selected from amantadine and rimantadine; ribavirin, and a neuraminidase inhibitor (NAi) in an amount that is antivirally effective in the combination, an oral dosage form containing 75-250 mg of the M2 inhibitor, an oral dosage form comprising 100-400 mg of ribavirin and a neuraminidase inhibitor are provided for the treatment of influenza. Some embodiments of the kits comprise an oral dosage form containing 75-250 mg of the M2 inhibitor, an oral dosage form comprising 100-400 mg of ribavirin, and a neuraminidase inhibitor.